NewSquare Capital’s Reviva Pharmaceuticals Warrants RVPHW Stock Holding History

NewSquare Capital’s Portfolio RVPHW Stock Details RVPHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-500	Closed	-$886	–	843
2023 Q2	$886	Hold	500	–	–	﹤0.01%	622
2023 Q1	$500	Hold	500	–	–	﹤0.01%	713
2022 Q4	$495	Buy	+500	New	+$427	﹤0.01%	653

Other funds holding RVPHW

Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

NewSquare Capital's RVPHW Position: Q3 2023 in Review

NewSquare Capital sold out of Reviva Pharmaceuticals Warrants (RVPHW) in Q3 2023, closing a stake of 500 shares — an estimated $886 sold.

NewSquare Capital first reported a position in RVPHW in Q4 2022 and held it in 3 quarters. The position peaked at $886 in Q2 2023. 4 funds tracked by Wall St. Rank hold RVPHW as of Q3 2023.

NewSquare Capital reported no remaining Reviva Pharmaceuticals Warrants position as of Q3 2023 after selling out during the quarter.
NewSquare Capital sold 500 Reviva Pharmaceuticals Warrants shares in Q3 2023, an estimated $886.
NewSquare Capital first reported a position in Reviva Pharmaceuticals Warrants in Q4 2022 and held it in 3 quarters.
NewSquare Capital's Reviva Pharmaceuticals Warrants position peaked at $886 in Q2 2023.
4 funds tracked by Wall St. Rank held Reviva Pharmaceuticals Warrants as of Q3 2023.

Based on NewSquare Capital's 13F filing for Q3 2023, filed 3 Nov 2023.